#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419673	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of RhoA-mediated phospho-MLC formation at 10 uM incubated for 24 hrs by densitometry	Homo sapiens	2		cell-based format	Patent Bioactivity Data
2.	ALA4419674	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of 10% calf serum-induced RhoA-GTP formation at 10 uM incubated for 24 hrs by densitometry relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
3.	ALA4419675	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of RhoA-mediated phospho-MLC formation incubated for 24 hrs by densitometry	Homo sapiens	2		cell-based format	Patent Bioactivity Data
4.	ALA4419676	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
5.	ALA4419679	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level at 30 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
6.	ALA4419680	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level at 10 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
7.	ALA4419681	B	Inhibition of RhoGEF in human MCF7 cells derived mammospheres assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level at 5 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
8.	ALA4419683	F	Inhibition of cell invasion of human MCF7 cells at 10 to 50 uM by Matrigel-coated transwell based assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
9.	ALA4419685	F	Inhibition of cell migration of human MCF7 cells at 10 to 50 uM	Homo sapiens	2		cell-based format	Patent Bioactivity Data
10.	ALA4419687	F	Growth inhibition of human MCF7 cells at 5 to 50 uM	Homo sapiens	2		cell-based format	Patent Bioactivity Data
11.	ALA4419689	B	Inhibition of RhoGEF in mouse NIH/3T3 cells assessed as inhibition of 10% calf serum-induced Rac1-GTP formation by measuring relative Rac1-GTP level at 50 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Mus musculus	2		cell-based format	Patent Bioactivity Data
12.	ALA4419691	B	Inhibition of RhoGEF in mouse NIH/3T3 cells assessed as inhibition of 10% calf serum-induced Cdc42-GTP formation by measuring relative Cdc42-GTP level at 50 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Mus musculus	2		cell-based format	Patent Bioactivity Data
13.	ALA4419696	B	Inhibition of RhoGEF in mouse NIH/3T3 cells assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level at 50 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Mus musculus	2		cell-based format	Patent Bioactivity Data
14.	ALA4419697	B	Inhibition of RhoGEF in mouse NIH/3T3 cells assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level at 30 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Mus musculus	2		cell-based format	Patent Bioactivity Data
15.	ALA4419698	B	Inhibition of RhoGEF in mouse NIH/3T3 cells assessed as inhibition of 10% calf serum-induced RhoA-GTP formation by measuring relative RhoA-GTP level at 10 uM incubated for 24 hrs by densitometry (Rvb = 1 No_unit)	Mus musculus	2		cell-based format	Patent Bioactivity Data
16.	ALA4419702	B	Binding affinity to human LARG (765 to 1138 residues) DH-PH module expressed in mouse NIH/3T3 cells assessed as reduction in LARG binding to human full length RhoA (1 to 193 residues) by measuring relative LARG binding level at 50 uM pull-down assay (Rvb = 1 No unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
17.	ALA4419703	B	Binding affinity to human LARG (765 to 1138 residues) DH-PH module expressed in mouse NIH/3T3 cells assessed as reduction in LARG binding to human full length RhoA (1 to 193 residues) by measuring relative LARG binding level at 30 uM pull-down assay (Rvb = 1 No unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
18.	ALA4419704	B	Binding affinity to human LARG (765 to 1138 residues) DH-PH module expressed in mouse NIH/3T3 cells assessed as reduction in LARG binding to human full length RhoA (1 to 193 residues) by measuring relative LARG binding level at 10 uM pull-down assay (Rvb = 1 No unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
19.	ALA4419705	B	Binding affinity to human LARG (765 to 1138 residues) DH-PH module expressed in mouse NIH/3T3 cells assessed as reduction in LARG binding to human full length RhoA (1 to 193 residues) by measuring relative LARG binding level at 5 uM pull-down assay (Rvb = 1 No unit)	Homo sapiens	2		cell-based format	Patent Bioactivity Data
20.	ALA4419706	B	Inhibition of RhoGEF in mouse NIH/3T3 cells assessed as reduction in 10% calf serum-induced rhoA-mediated actin stress fiber formation at 10 uM by rhodamine-phalloidin staining based assay	Mus musculus	2		cell-based format	Patent Bioactivity Data